[Studies on the solid Walker-carcinosarcoma 256 in the rat during administration of cytostatics].
D000704:Analysis of Variance; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D002279:Carcinoma 256, Walker / Q000188:drug therapy* / Q000473:pathology; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004305:Dose-Response Relationship, Drug; D066298:In Vitro Techniques; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D009363:Neoplasm Proteins / Q000096:biosynthesis; D011344:Procarbazine / Q000627:therapeutic use; D012334:RNA, Neoplasm / Q000096:biosynthesis; D051381:Rats; D014228:Triaziquone / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001565:Benzoates; D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D011344:Procarbazine; D014228:Triaziquone; D008727:Methotrexate
Untersuchungen am soliden Walker-Karinosarkom 256 der Ratte unfer Einwirkung von Zytostafika.